CoChat
Sign Up
Cited by 24

The DOI matches its Crossref record.

Genetic demonstration of intestinal NPC1L1 as a major determinant of hepatic cholesterol and blood atherogenic lipoprotein levels

Xie, Ping, Zhu, Hongling, Jia, Lin, Ma, Yinyan, Tang, Weiqing, Wang, Youlin, Xue, Bingzhong, Shi, Hang, Yu, Liqing·2014·Atherosclerosis
DOI 10.1016/j.atherosclerosis.2014.09.036PMC PMC4262594
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.atherosclerosis.2014.09.036

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 49

  1. Wilson, 1980, Prevalence of coronary heart disease in the Framingham Offspring Study: role of lipoprotein cholesterols, Am. J. Cardiol., 46, 649, 10.1016/0002-9149(80)90516-0 · DOI
  2. Dietschy, 1993, Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans, J. Lipid Res., 34, 1637, 10.1016/S0022-2275(20)35728-X · DOI · Paper page
  3. Van Heek, 1997, In vivo metabolism-based discovery of a potent cholesterol absorption inhibitor, SCH58235, in the rat and rhesus monkey through the identification of the active metabolites of SCH48461, J. Pharmacol. Exp. Ther., 283, 157, 10.1016/S0022-3565(24)36992-7 · DOI
  4. Brown, 1978, Induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts incubated with compactin (ML-236B), a competitive inhibitor of the reductase, J. Biol. Chem., 253, 1121, 10.1016/S0021-9258(17)38120-6 · DOI
  5. Bays, 2001, Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: pooled analysis of two phase II studies, Clin. Ther., 23, 1209, 10.1016/S0149-2918(01)80102-8 · DOI
  6. Davies, 2000, Evidence for a Niemann-pick C (NPC) gene family: identification and characterization of NPC1L1, Genomics, 65, 137, 10.1006/geno.2000.6151 · DOI
  7. Altmann, 2004, Niemann-Pick C1 like 1 protein is critical for intestinal cholesterol absorption, Science, 303, 1201, 10.1126/science.1093131 · DOI
  8. Garcia-Calvo, 2005, The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1), Proc. Natl. Acad. Sci. U. S. A., 102, 8132, 10.1073/pnas.0500269102 · DOI · Paper page
  9. Weinglass, 2008, Extracellular loop C of NPC1L1 is important for binding to ezetimibe, Proc. Natl. Acad. Sci. U. S. A., 105, 11140, 10.1073/pnas.0800936105 · DOI
  10. Yu, 2006, Cholesterol-regulated translocation of NPC1L1 to the cell surface facilitates free cholesterol uptake, J. Biol. Chem., 281, 6616, 10.1074/jbc.M511123200 · DOI
  11. Temel, 2007, Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe, J. Clin. Invest., 117, 1968, 10.1172/JCI30060 · DOI
  12. Tang, 2006, Plasma cholesterol is hyperresponsive to statin in ABCG5/ABCG8 transgenic mice, Hepatology, 44, 1259, 10.1002/hep.21380 · DOI
  13. Davies, 2005, Inactivation of NPC1L1 causes multiple lipid transport defects and protects against diet-induced hypercholesterolemia, J. Biol. Chem., 280, 12710, 10.1074/jbc.M409110200 · DOI
  14. Davis, 2004, Niemann-Pick C1 like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis, J. Biol. Chem., 279, 33586, 10.1074/jbc.M405817200 · DOI · Paper page
  15. Jia, 2010, Niemann-Pick C1-Like 1 deletion in mice prevents high-fat diet-induced fatty liver by reducing lipogenesis, J. Lipid Res., 51, 3135, 10.1194/jlr.M006353 · DOI
  16. Jia, 2010, Dietary cholesterol reverses resistance to diet-induced weight gain in mice lacking Niemann-Pick C1-Like 1, J. Lipid Res., 51, 3024, 10.1194/jlr.M008599 · DOI
  17. Labonte, 2008, Reduced absorption of saturated fatty acids and resistance to diet-induced obesity and diabetes by ezetimibe-treated and Npc1l1−/− mice, Am. J. Physiol. Gastrointest. Liver Physiol., 295, G776, 10.1152/ajpgi.90275.2008 · DOI
  18. Davis, 2007, Deficiency of Niemann-Pick C1 Like 1 prevents atherosclerosis in ApoE−/− mice, Arterioscler. Thromb. Vasc. Biol., 27, 841, 10.1161/01.ATV.0000257627.40486.46 · DOI
  19. Kesaniemi, 1987, Cholesterol absorption efficiency regulates plasma cholesterol level in the Finnish population, Eur. J. Clin. Invest., 17, 391, 10.1111/j.1365-2362.1987.tb01132.x · DOI
  20. Cohen, 2006, Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels, Proc. Natl. Acad. Sci. U. S. A., 103, 1810, 10.1073/pnas.0508483103 · DOI
  21. Bosner, 1999, Percent cholesterol absorption in normal women and men quantified with dual stable isotopic tracers and negative ion mass spectrometry, J. Lipid Res., 40, 302, 10.1016/S0022-2275(20)33370-8 · DOI
  22. Sehayek, 1998, U-shape relationship between change in dietary cholesterol absorption and plasma lipoprotein responsiveness and evidence for extreme interindividual variation in dietary cholesterol absorption in humans, J. Lipid Res., 39, 2415, 10.1016/S0022-2275(20)33320-4 · DOI
  23. Madison, 2002, Cis elements of the villin gene control expression in restricted domains of the vertical (crypt) and horizontal (duodenum, cecum) axes of the intestine, J. Biol. Chem., 277, 33275, 10.1074/jbc.M204935200 · DOI
  24. Garber, 2000, A sensitive and convenient method for lipoprotein profile analysis of individual mouse plasma samples, J. Lipid Res., 41, 1020, 10.1016/S0022-2275(20)32045-9 · DOI
  25. Siri, 2001, Post-transcriptional stimulation of the assembly and secretion of triglyceride-rich apolipoprotein B lipoproteins in a mouse with selective deficiency of brown adipose tissue, obesity, and insulin resistance, J. Biol. Chem., 276, 46064, 10.1074/jbc.M108909200 · DOI
  26. Li, 2011, Effects of antisense-mediated inhibition of 11beta-hydroxysteroid dehydrogenase type 1 on hepatic lipid metabolism, J. Lipid Res., 52, 971, 10.1194/jlr.M013748 · DOI
  27. Valasek, 2005, Caveolin-1 is not required for murine intestinal cholesterol transport, J. Biol. Chem., 280, 28103, 10.1074/jbc.M504609200 · DOI
  28. Roth, 2009, Generation of a tightly regulated doxycycline-inducible model for studying mouse intestinal biology, Genesis, 47, 7, 10.1002/dvg.20446 · DOI
  29. Repa, 2000, Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers, Science, 289, 1524, 10.1126/science.289.5484.1524 · DOI
  30. Rashid, 2005, Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9, Proc. Natl. Acad. Sci. U. S. A., 102, 5374, 10.1073/pnas.0501652102 · DOI · Paper page
  31. Grundy, 1983, Absorption and metabolism of dietary cholesterol, Annu. Rev. Nutr., 3, 71, 10.1146/annurev.nu.03.070183.000443 · DOI
  32. Yu, 2002, Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion, Proc. Natl. Acad. Sci. U. S. A., 99, 16237, 10.1073/pnas.252582399 · DOI
  33. Yu, 2002, Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol, J. Clin. Invest., 110, 671, 10.1172/JCI0216001 · DOI
  34. Graf, 2002, Coexpression of ATP-binding cassette proteins ABCG5 and ABCG8 permits their transport to the apical surface, J. Clin. Invest., 110, 659, 10.1172/JCI0216000 · DOI
  35. Davis, 2001, Ezetimibe, a potent cholesterol absorption inhibitor, inhibits the development of atherosclerosis in ApoE knockout mice, Arterioscler. Thromb. Vasc. Biol., 21, 2032, 10.1161/hq1201.100260 · DOI · Paper page
  36. Davis, 2011, Effects of ezetimibe on atherosclerosis in preclinical models, Atherosclerosis, 215, 266, 10.1016/j.atherosclerosis.2011.02.010 · DOI
  37. Repa, 2005, Delineation of molecular changes in intrahepatic cholesterol metabolism resulting from diminished cholesterol absorption, J. Lipid Res., 46, 779, 10.1194/jlr.M400475-JLR200 · DOI
  38. Gagne, 2002, Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia, Circulation, 105, 2469, 10.1161/01.CIR.0000018744.58460.62 · DOI
  39. Wang, 2007, Regulation of intestinal cholesterol absorption, Annu. Rev. Physiol., 69, 221, 10.1146/annurev.physiol.69.031905.160725 · DOI
  40. Xie, 2012, Ezetimibe blocks the internalization of NPC1L1 and cholesterol in mouse small intestine, J. Lipid Res., 53, 2092, 10.1194/jlr.M027359 · DOI · Paper page
  41. Rudel, 2001, Acyl coenzyme A: cholesterol acyltransferase types 1 and 2: structure and function in atherosclerosis, Curr. Opin. Lipidol., 12, 121, 10.1097/00041433-200104000-00005 · DOI
  42. Xie, 2002, Fatty acids differentially regulate hepatic cholesteryl ester formation and incorporation into lipoproteins in the liver of the mouse, J. Lipid Res., 43, 1508, 10.1194/jlr.M200146-JLR200 · DOI
  43. Telford, 2007, The molecular mechanisms underlying the reduction of LDL apoB-100 by ezetimibe plus simvastatin, J. Lipid Res., 48, 699, 10.1194/jlr.M600439-JLR200 · DOI
  44. Greeve, 1993, Apolipoprotein B mRNA editing in 12 different mammalian species: hepatic expression is reflected in low concentrations of apoB-containing plasma lipoproteins, J. Lipid Res., 34, 1367, 10.1016/S0022-2275(20)36966-2 · DOI
  45. Warnakula, 2011, New insights into how the intestine can regulate lipid homeostasis and impact vascular disease: frontiers for new pharmaceutical therapies to lower cardiovascular disease risk, Can. J. Cardiol., 27, 183, 10.1016/j.cjca.2010.12.020 · DOI
  46. Phillips, 2000, Improved metabolic control reduces the number of postprandial apolipoprotein B-48-containing particles in type 2 diabetes, Atherosclerosis, 148, 283, 10.1016/S0021-9150(99)00275-0 · DOI
  47. Mamo, 2001, Postprandial dyslipidemia in men with visceral obesity: an effect of reduced LDL receptor expression?, Am. J. Physiol. Endocrinol. Metabol., 281, E626, 10.1152/ajpendo.2001.281.3.E626 · DOI
  48. Adeli, 2008, Intestinal lipoprotein overproduction in insulin-resistant states, Curr. Opin. Lipidol., 19, 221, 10.1097/MOL.0b013e3282ffaf82 · DOI
  49. Su, 2009, Impaired postprandial metabolism of apolipoprotein B48-containing remnant particles in normolipidemic subjects with brittle type 1 diabetes, Diabetes Care, 32, e21, 10.2337/dc08-1573 · DOI

Cited by

Sorted by citations

Metadata

Authors
Xie, P., Zhu, H., Jia, L., Ma, Y., Tang, W., Wang, Y., Xue, B., Shi, H., & Yu, L.
Venue
Atherosclerosis
Publisher
Elsevier BV
Published
2014-12
Volume
237
Issue
2
Pages
609-617
ISSN
0021-9150
DOI
10.1016/j.atherosclerosis.2014.09.036
PMC
PMC4262594
Cited by
24
References
0
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review